title: Cytotoxic T-cell clone against rectal carcinoma induced by stimulation of a patient's peripheral blood mononuclear cells with autologous cultured tumor cells.
abstract: In an effort to establish cytolytic T lymphocytes (CTLs) against colorectal carcinoma (CRC) by stimulating patients' lymphocytes with autologous tumor cells, we used peripheral blood mononuclear cells (PBMC) from a patient with minimal residual rectal carcinoma following removal of the primary lesion and involved regional lymph nodes as a source to generate CTLs in culture. A CTL line and clone were established from the patient's PBMC following stimulation of PBMC with autologous, cultured tumor cells and interleukin-2. The CTL line and the clone consisted predominantly of CD4+ lymphocytes. The CTL clone expressed two T-cell receptor variable alpha chains (V alpha11 and V alpha22) and one beta chain (Vbeta14). The cytokine secretion pattern of the CTL line was of the Th1-type. Both the CTL line and the clone lysed the autologous rectal carcinoma cells, but not the allogeneic, partially human lymphocyte antigen (HLA)-matched or nonmatched CRC cells, autologous Epstein-Barr virus-transformed B cells, K562 (natural killer target) cells or Daudi (lymphokine-activated killer target) cells. Lysis of autologous tumor cells most likely was HLA class I-restricted. Our unique success in generating CTLs against this tumor type may rest in the inclusion of a patient with minimal residual, rather than advanced, disease.
authors.affiliation: The Wistar Institute, Philadelphia, PA 19104, USA.
authors.forename: L
authors.initials: L
authors.lastname: Jacob
authors.forename: R
authors.initials: R
authors.lastname: Somasundaram
authors.forename: W
authors.initials: W
authors.lastname: Smith
authors.forename: D
authors.initials: D
authors.lastname: Monos
authors.forename: S
authors.initials: S
authors.lastname: Basak
authors.forename: F
authors.initials: F
authors.lastname: Marincola
authors.forename: S
authors.initials: S
authors.lastname: Pereira
authors.forename: D
authors.initials: D
authors.lastname: Herlyn
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002478:Cells, Cultured; D002999:Clone Cells; D003602:Cytotoxicity, Immunologic; D017931:DNA Primers; D005260:Female; D015870:Gene Expression; D006650:Histocompatibility Testing; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000276:immunology; D008207:Lymphatic Metastasis; D008213:Lymphocyte Activation; D051379:Mice; D016513:Mice, SCID; D008875:Middle Aged; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000096:biosynthesis / Q000235:genetics; D012004:Rectal Neoplasms / Q000097:blood / Q000276:immunology* / Q000473:pathology*; D013601:T-Lymphocytes / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured
chemical_list: D017931:DNA Primers; D007376:Interleukin-2; D016693:Receptors, Antigen, T-Cell, alpha-beta